Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Rhabdomyosarcoma 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Medulloblastoma 1 Hemangiosarcoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

Cyclophosphamide 20 Etoposide 19 Temozolomide 16 Carboplatin 16 Filgrastim 15 Vincristine 11 Cisplatin 11 Radiotherapy 10 Thiotepa 9 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 etoposide phosphate 7 Lomustine 7 Peripheral Blood Stem Cell Transplantation 6 Radiation 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Topotecan 4 Mesna 4 Gemcitabine 4 Busulfan 4 sargramostim 3 gallium Ga 68 dotatate 3 Thalidomide 3 Stem Cell Transplantation 3 Irinotecan 3 Ifosfamide 3 Donepezil 3 Celecoxib 3 Automobiles 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Medulloblastoma × Vascular Endothelial Growth Factor A × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡